Search research articles
Contact Us
Filters
Showing results (41-50 of 300) with videos related to
Page
of 30
Sort By:
The New Zealand Medical Journal
|
February 20, 2014
Improving outcomes for New Zealand men with prostate cancer
John N Nacey, Brett Delahunt, Stephen D Mark
European Urology
|
May 14, 2019
Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question
Murali Varma, Brett Delahunt, Theodorus van der Kwast
The New Zealand Medical Journal
|
January 13, 2012
PSA testing--who should decide when it is performed?
David S Lamb, Brett Delahunt, John N Nacey
Pathology
|
March 2, 2013
Premalignant lesions of the urinary bladder
Hemamali Samaratunga, Guido Martignoni, Lars Egevad, et al.
Histopathology
|
December 20, 2016
Reply: 'A plea for greater standardization in intraductal carcinoma of the prostate -greater standardization requires greater evidence': let's use the available evidence
Murali Varma, Lars Egevad, Brett Delahunt, et al.
Pathology
|
December 17, 2009
Gleason grading: consensus and controversy
Brett Delahunt, John R Srigley, David S Lamb
The New Zealand Medical Journal
|
November 11, 2011
Revised status of PSA testing in the early detection and treatment of prostate cancer
David S Lamb, Brett Delahunt, John N Nacey
Pathology International
|
January 30, 2019
Evolution, controversies and the future of prostate cancer grading
Lars Egevad, Brett Delahunt, John Yaxley, et al.
Human Pathology
|
December 17, 2009
Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension
Hemamali Samaratunga, David Duffy, John Yaxley, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
December 6, 2018
The current status of renal cell carcinoma and prostate carcinoma grading
Brett Delahunt, Lars Egevad, John Yaxley, et al.
Page
of 30
Search research articles
Search
Showing results (41-50 of 300) with videos related to
Sort By:
Page
of 30
The New Zealand Medical Journal
|
February 20, 2014
Improving outcomes for New Zealand men with prostate cancer
John N Nacey, Brett Delahunt, Stephen D Mark
European Urology
|
May 14, 2019
Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question
Murali Varma, Brett Delahunt, Theodorus van der Kwast
The New Zealand Medical Journal
|
January 13, 2012
PSA testing--who should decide when it is performed?
David S Lamb, Brett Delahunt, John N Nacey
Pathology
|
March 2, 2013
Premalignant lesions of the urinary bladder
Hemamali Samaratunga, Guido Martignoni, Lars Egevad, et al.
Histopathology
|
December 20, 2016
Reply: 'A plea for greater standardization in intraductal carcinoma of the prostate -greater standardization requires greater evidence': let's use the available evidence
Murali Varma, Lars Egevad, Brett Delahunt, et al.
Pathology
|
December 17, 2009
Gleason grading: consensus and controversy
Brett Delahunt, John R Srigley, David S Lamb
The New Zealand Medical Journal
|
November 11, 2011
Revised status of PSA testing in the early detection and treatment of prostate cancer
David S Lamb, Brett Delahunt, John N Nacey
Pathology International
|
January 30, 2019
Evolution, controversies and the future of prostate cancer grading
Lars Egevad, Brett Delahunt, John Yaxley, et al.
Human Pathology
|
December 17, 2009
Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension
Hemamali Samaratunga, David Duffy, John Yaxley, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
December 6, 2018
The current status of renal cell carcinoma and prostate carcinoma grading
Brett Delahunt, Lars Egevad, John Yaxley, et al.
Page
of 30